AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RIVAROXABAN TABLETS 10 MG
6 registrations across 4 African markets— 6 active
Markets with RIVAROXABAN TABLETS 10 MG
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Rivaroxaban Tablets 10 mg Tablets+ Filmcoated | 🇿🇲Zambia | Cipla Ltd | active | Mar 2031 |
| VAROXA-10 Uncoated tablets | 🇷🇼Rwanda | MICRO LABS LIMITED, | active | Dec 2028 |
| Rivaroxaban Tablets 10 mg Film-Coated Tablet | 🇰🇪Kenya | Cipla Limited | active | Aug 2028 |
| ZEROBAN 10 Film-Coated Tablet | 🇰🇪Kenya | AVETINA LIFE SCIENCES LTD | active | Apr 2028 |
| RIVEIN 10 Tablets | 🇹🇿Tanzania | ATRA PHARMACEUTICALS LIMITED | active | — |
| JBRIVO 10 Film Coated Tablet | 🇹🇿Tanzania | UNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd) | active | — |
RIVAROXABAN TABLETS 10 MG in Africa — Regulatory Overview
RIVAROXABAN TABLETS 10 MG is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Tanzania, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.